[Hepatotoxicity of rifampicin-rifamycin SV in the treatment of tuberculous meningitis (author's transl)].
D000293:Adolescent; D000328:Adult; D000410:Alanine Transaminase / Q000378:metabolism; D001219:Aspartate Aminotransferases / Q000378:metabolism; D001706:Biopsy; D056486:Chemical and Drug Induced Liver Injury; D005260:Female; D006801:Humans; D008099:Liver / Q000187:drug effects* / Q000201:enzymology / Q000473:pathology; D008297:Male; D008875:Middle Aged; D012293:Rifampin / Q000009:adverse effects; D012294:Rifamycins / Q000009:adverse effects*; D013194:Staining and Labeling; D014390:Tuberculosis, Meningeal / Q000188:drug therapy*
D012294:Rifamycins; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D012293:Rifampin
Zur Lebertoxizität der Rifamycine bei der Behandlung tuberkulöser Meningitiden.